BMS-819881 manufacturers
- BMS-819881
-
- $1520.00
-
2026-04-21
- CAS:1197420-05-5
- Purity:
- Supply Ability: 10g
- BMS-819881
-
- $1520.00
-
2025-07-17
- CAS:1197420-05-5
- Purity:
- Supply Ability: 10g
|
| | BMS-819881 Basic information |
| Product Name: | BMS-819881 | | Synonyms: | BMS-819881;Thieno[3,2-d]pyrimidin-4(3H)-one, 6-(4-chlorophenyl)-3-[4-[(2R)-2-cyclopropyl-2-hydroxyethoxy]-3-methoxyphenyl]-;BMS819881,BMS 819881;(R)-6-(4-chlorophenyl)-3-(4-(2-cyclopropyl-2-hydroxyethoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one | | CAS: | 1197420-05-5 | | MF: | C24H21ClN2O4S | | MW: | 468.95 | | EINECS: | | | Product Categories: | | | Mol File: | 1197420-05-5.mol |  |
| | BMS-819881 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Soluble in DMSO |
| | BMS-819881 Usage And Synthesis |
| Uses | BMS 819881, is a potent and highly selective MCHR1 functional antagonist. It has how shown high selectivity towards CYP3A4 activity with an EC50 of 13 μM. | | in vivo | BMS-819881 has moderate terminal elimination half-life (t1/2=5.7 h, 32±8 h, and 14±3 h for rat (1 mg/kg, iv), dog (1 mg/kg, iv), and cynomologous monkey (1 mg/kg, iv))[1]. | | IC 50 | rat MCHR1: 7 nM (Ki); CYP3A4: 13 μM (EC50) |
| | BMS-819881 Preparation Products And Raw materials |
|